Low CD4+ T cell counts disrupt the balance between pro- and anti-inflammatory signaling.The increased inflammation promotes endothelial activation and dysfunction, promoting plaque formation and ASCVD progression. This evidence concerns the gene CD4 and atherosclerosis.